Form 8-K - Current report:
SEC Accession No. 0001477932-22-008634
Filing Date
2022-11-15
Accepted
2022-11-15 16:05:20
Documents
16
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K upxi_8k.htm   iXBRL 8-K 24786
2 PRESS RELEASE upxi_ex991.htm EX-99.1 134593
8 upxi_ex991img2.jpg GRAPHIC 5326
  Complete submission text file 0001477932-22-008634.txt   301462

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA upxi-20221114.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE upxi-20221114_lab.xml EX-101.LAB 14660
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE upxi-20221114_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE upxi-20221114_pre.xml EX-101.PRE 9272
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE upxi-20221114_def.xml EX-101.DEF 2099
10 EXTRACTED XBRL INSTANCE DOCUMENT upxi_8k_htm.xml XML 3575
Mailing Address 17129 US HWY 19 N. CLEARWATER FL 33760
Business Address 17129 US HWY 19 N. CLEARWATER FL 33760 701-353-5425
UPEXI, INC. (Filer) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-40535 | Film No.: 221391171
SIC: 2833 Medicinal Chemicals & Botanical Products